arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

X4 Pharmaceuticals, Inc.

XFOR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$4.04
Today
as of Sep 4, 16:56 ET
Last 30 days +2.54% Jul 27 → Sep 04
$3.87 $4.08 $4.28 $4.49 $4.70 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$4.01
High
$4.08
Low
$4.00
Volume
$168,162
Avg Vol
$662,320
Mkt Cap
$400M
P/E (TTM)
Beta
52w High
$4.83
52w Low
$2.80
Div Yield
Shares Out
$96M

Recent Press Releases & News last 60 days · 2 items

Overview

52-week range
$2.80
$4.83
61% of range
Avg surprise (last 3)
+48.1%
Avg reaction (last 2)
-4.4%
50% positive
Latest IV / EM
570%
EM ±33.7% · $5 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-7.77$-2.43$2.90$8.23$13.57 Actual $-0.16Actual $-0.33Actual $-0.01Actual $-7.77Actual $13.57Actual $-5.48Actual $0.04Est $-4.13Actual $-3.47Est $-4.53Actual $-0.69Actual $-0.16Est $-0.20Actual $-0.13 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-37M$-27M$-17M$-7M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.13 financials
Wed May 6, 2026Mar/2026 $-0.16 $-0.20 +20.0% -500.0% +4.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.69 financials
Fri Aug 8, 2025Jun/2025 $-3.47 $-4.53 +23.4% earnings
Thu May 1, 2025Mar/2025 $0.04 $-4.13 +101.0% -13.0% earnings
Mon Sep 30, 2024Sep 2024 $-5.48 financials
Sun Jun 30, 2024Jun 2024 $13.57 financials
Sun Mar 31, 2024Mar 2024 $-7.77 financials
Sat Sep 30, 2023Sep 2023 $-0.01 financials
Fri Jun 30, 2023Jun 2023 $-0.33 financials
Fri Mar 31, 2023Mar 2023 $-0.16 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$2M$2M$2M$2M$900,000$560,000
Cost of revenue$2M$598,000$351,000$326,000$5M$227,000
Gross profit
Operating income$-16M$-20M$-28M$-26M$-9M$-34M
Net income$-16M$-20M$-30M$-26M$282,000$-37M
EPS (diluted)$-0.13$-0.16$-0.69$-3.47$0.04$-5.48

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$195M$217M$217M$70M$39M$40M$56M$97M
Inventory
Total current assets$219M$242M$262M$133M$73M$96M$112M$143M
Total assets$253M$270M$290M$164M$105M$130M$146M$178M
Long-term debt$75M$75M$75M$75M$75M$75M$75M
Total liabilities$98M$102M$104M$102M$101M$107M$124M$119M
Total equity$155M$168M$186M$62M$4M$23M$22M$60M

Implied volatility — last 90 days

569%680%791%902%1012% Jul 07 — IV 961% · EM ±126.9%Jul 08 — IV 1013% · EM ±126.9%Jul 22 — IV 603% · EM ±137.8%Jul 23 — IV 590% · EM ±132.6%Jul 31 — IV 656% · EM ±125.6%Aug 06 — IV 741% · EM ±119.9%Aug 07 — IV 764% · EM ±119.3%Aug 19 — IV 570% · EM ±33.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.